Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three months and six months ended September 30, 2013.
Quarter ended September 30, 2013 Highlights - compared to September 30, 2012
•Net sales of $205.3 million, increased $44.3 million, or 27.5%, with slight increase in volumes
Help employers find you! Check out all the jobs and post your resume.
